Article in Fin Review Jan 16/17 2010
*Biota Expects sales increase this year
*Relenza royalties from Glaxo more than doubled in 2009
*Glaxo intend to triple annual production this year
*Governments worldwide are increasing their Relenza
stockpiles.
Very positive outlook for this year.